已发表文章
2025年
65. Ling-yu She#, Lu-yao Li#, Hao Tang#, Qin Yu, Feng-yi Gao, Yu-qing Zeng, Lin-jie Chen, Li Xiong, Li-wei Li, Fan Chen, Jin-feng Sun, Wen-hua Zheng, Xia Zhao*, Guang Liang*. OTUD1 positively regulates microglia neuroinflammation and promotes the pathogenesis of Alzheimer's disease by deubiquitinating C/EBPβ, Acta Pharmacologica Sinica, 2025, Accepted. (一区，IF=6.9)
64. Xuejin Jin, Miao Yuan, Lingkun Wang, Huiyan Zha, Zhiwei Zheng, Zheng Xu, Jing Shi, Guang Liang, Qian Zhou. Curcumol Ameliorates Cisplatin-induced Nephrotoxicity by Targeting TAK1 and Inhibiting MAPK and NF-κB Pathways. Phytomedicine, 2025, Accepted. (一区， IF=6.7)
63. Haibin Wu, Shuhan Shi, Lenan Xu, Ziying Zheng, Ziyan Huang, Yi Qiu, Jixiang Zhang, Keyun Yang, Yuting Xie, Cheng Xu, Tianyang Xu, Guohuan Zeng, Lingfeng Chen, Mincong Huang, Qian Chen*, Daishun Ling*, Guang Liang*, Nanozyme engineered ROS-tolerant cysteine active-site for upstream deubiquitylation therapy of inflammatory bowel disease, Nano Today, 2025, Accepted. (一区，IF=13.2）
62. Zhuqi Huang#, Sirui Shen#, Weixin Li, Mengyang Wang, Yudie Yang, Wu Luo, Xue Han, Zheng Xu, Julian Min, Xiaohong Long, Weijian Huang, Gaojun Wu, Yi Wang*, Guang Liang*. Macrophage WEE1 Directly Binds to and Phosphorylates NF-κB p65 Subunit to Induce Inflammatory Response and Drive Atherosclerosis, Advanced Science, 2025, Accepted. (一区，IF=14.3)
61. Bozhi Ye#, Diyun Xu#, Lingfeng Zhong#, Yi Wang, Wei Wang, Haowen Xu, Xue Han, Julian Min, Gaojun Wu, Wenhai Huang*, Guang Liang*. USP25 improves myocardial ischemia-reperfusion injury by deubiquitinating NLRP3 and negatively regulating NLRP3 inflammasome activity in cardiomyocytes, Clinical and Translational Medicine, 2025, Accepted. (一区，IF=7.9）
60. Xue Han#, Qiaojuan Shi#, Yu Tu, Jiajia Zhang, Mengyang Wang, Weiqi Li, Yanan Liu, Ruyi Zheng, Jiajia Wei, Shiju Ye, Yanmei Zhang, Bozhi Ye, Yi Wang, Huazhong Ying*, Guang Liang*. Cardiomyocyte PRL2 Promotes Cardiac Hypertrophy via Directly Dephosphorylating AMPKα2, Circulation Research, 2025, Accepted. (一区，IF=16.5)
59. Hao Tang#, Luyao Li#, Qin Yu, Linjie Chen, Xiaoxia Xu, Ziyao Meng, Yuqing Zeng, Fan Chen, Hammad Muzaffar, Wei Wang*, Xia Zhao* and Guang Liang*. Sclareol improves the pathology of Alzheimer's disease by inhibiting microglial inflammation via interacting with CDK9. Phytomedicine, 2025, Accepted.(一区，IF=6.7)
58. Yaoxiang Lin, Lulu Zheng, Ying Xu, Xinyan Wang, Jie Li, Lei Zheng*, Guang Liang* and Lingfeng Chen*. Interleukin‑1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects. Journal of Medicinal Chemistry, 2025, Accepted.(一区，IF=6.9)
57. Xin Liu#, Yi Fang#, Mincong Huang, Shiliang Tu, Mengyao Lan, Boan Zheng, Hang Yuan, Peng Yu, Yongqiang Zhou, Wu Luo, Guorong Chen, Zhe Shen, Yi Wang, Guang Liang*. Deubiquitinase JOSD2 alleviates colitis by inhibiting inflammation via deubiquitination of IMPDH2 in macrophages. Acta Pharmaceutica Sinica B. 2025;15(2):1039e1055. (一区, IF=14.5)[
57-2025.pdf]
56. Jinfeng Sun#, Fan Chen#, Lingyu She, Yuqing Zeng, Hao Tang, Bozhi Ye, Wenhua Zheng, Li Xiong, Liwei Li, Luyao Li, Qin Yu, Linjie Chen, Wei Wang, Guang Liang*, Xia Zhao*. YOD1 regulates microglial homeostasis by deubiquitinating MYH9 to promote the pathogenesis of Alzheimer's disease. Acta Pharmaceutica Sinica B. 2025;15(1):331-348.(一区, IF=14.5)[56-2025.pdf]
2024年
55. Huimin Jin#, Fan Zhou#, Zhenhua Xiang, Lingfeng Chen, Guang Liang*, Patrick J. Walsh* and Jie Lia*. Base-Promoted Synthesis of N-H Free Pyrroles via net [3+2]-Cycloaddition. Adv. Synth. Catal. 2024, 366, 942 – 947(二区，IF=4.4)[55-2024.pdf]
54. Sujuan Shuai#, Jianyou Mao#, Fan Zhou#, Qifeng Yan, Lingfeng Chen, Jie Li*, Patrick J. Walsh* and Guang Liang*. Base-Promoted Synthesis of Isoquinolines through a Tandem Reaction of 2‑Methyl-arylaldehydes and Nitriles. The Journal of Organic Chemistry, 2024, 89, 6793−6797.(二区，IF=3.3)[54-2024.pdf]
53. Wanxin Yao#, Chen Liu#, Ningyin Zhang, Yanmei Zhang* and YONG QIAN*. Atractyloside inhibits gefitinib‑resistant non‑small‑cell lung cancer cell proliferation. Oncology Letters, 2024, 28: 466.(四区，IF=2.5)[53-2024.pdf]
52. Liwei Li#; Jinfeng Sun#; Fan Chen; Li Xiong; Lingyu She; Hao Tang; Yuqing Zeng; Luyao Li; Wei Wang; Xia Zhao*; Guang Liang*. Pedunculoside alleviates cognitive deficits and neuronal cell apoptosis by activating the AMPK signaling cascade. Chinese Medicine, 2024,19:163. (二区，IF=5.3)[52-2024.pdf]
51. Mengyao Lan, Cailu Lin, Lulu Zeng, Shijie Hu, Yuan Shi, Yan Zhao, Xin Liu, Jinfeng Sun, Guang Liang*, Mincong Huang*. Linderanine C regulates macrophage polarization by inhibiting the MAPK signaling pathway against ulcerative colitis. Biomedicine & Pharmacotherapy, 2024，178：17239.（一区，IF=6.9）[51-2024.pdf]
50. Yuqing Zeng#, Li Xiong#, Hao Tang, Linjie Chen, Qin Yu, Liwei Li, Fan Chen, Luyao Li, Yanyan Zheng, Jinfeng Sun, Lingyu She, Wei Wang*, Guang Liang* and Xia Zhao*. Norboldine improves cognitive impairment and pathological features in Alzheimer's Disease by activating AMPK/GSK3β/Nrf2 signaling pathway. Journal of Ethnopharmacology，2024，333: 118498. (一区，5.4)[50-2024.pdf]
49. Xiaobo Li, Xinyi Huang, Yunxi Zhao, Zhiwei Zheng, Mi Guo, Zhicao Chen, Pan Chen, Xiang Li, Jing Liao, Miao Jiang, Won-Jea Cho, Young-Chang Cho, Ruifeng Zeng*, Qidong Tang*, Guang Liang*. Design, synthesis and bioactivity evaluation of 4-hydroxycoumarin derivatives as potential anti-inflammatory agents against acute lung injury and colitis. European Journal of Medicinal Chemistry, 2024, 272: 116487. （一区，IF=6.7）[49-2024.pdf]
48. Lintao Wang, Wu Luo, Suya Zhang, Junsheng Zhang, Lu He, Yifan Shi, Li Gao, Baochuan Wu, Xiaoyan Nie, Chenghong Hu, Xue Han, Chaoyong He*, Biao Xu*, Guang Liang*. Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signaling pathway. Cardiovascular Research, 2024 120(12):1385-1399.（一区，IF=10.8）[48-2024.pdf]
47. Lingfeng Chen*#, Ruixiang Luo#, Lin Ma#, Ying Xu#, Jiaqi Cao, Zheng Jiang, Lei Zheng, Yawen Zhang, Lina Yin, Jie Yu, Xiaochun Zheng, Lulu Zheng, Ping Huang, Guang Liang*. Discovery of LC-MI-3: a potent and orally bioavailable degrader of interleukin-1 receptor associated kinase 4 for the treatment of inflammatory diseases. Journal of Medicinal Chemistry, 2024,67, 8060−8076. (一区，IF=7.3)[47-2024.pdf]
46. Xiaoyu Sun, Tong Wu, Zhan Yang, Shuhong Chen, Zheyu Zhao, Chaoming Hu, Shengzhuang Wu, Jiayu Wu, Yixin Mao, Jiefan Liu, Chen Guo, Gang Cao, Xiangwei Xu*, Shengbin Huang*, Guang Liang*. Regulatory role of PDK1 via integrated gene analysis of mitochondria-immune response in periodontitis. Gene, 2024,918:148476. （三区，IF=3.5)[46-2024.pdf]
45. Jiamin Wang#, Sujuan Shuai#, Lishe Gan#, Yongxin Luo, Huimin Jin, Lingfeng Chen, Dong Zou, Guang Liang*, Patrick J. Walsh* and Jie Li*. Cation-controlled chemoselective synthesis ofN-aroylureas and imides via amidation of N-Bocarylamides. Organic Chemistry Frontiers， 2023，10：2061-2069. (一区，IF=5.4）[45-2023.pdf]
44. Ao Wang, Yi Zhang, Xinting Lv, Guang Liang*. Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases. Acta Pharmaceutica Sinica B, 2024,14(8):3295-3318. (一区，IF=14.5）[44-2024.pdf]
43. Binhao Cai#, Ying Xu#, Ruixiang Luo#, Kongqin Lu, Yuhan Wang, Lei Zheng, Yawen Zhang, Lina Yin, Linglan Tu, Wu Luo, Lulu Zheng, Fengzhi Zhang, Xinting Lv, Qidong Tang*, Guang Liang*, Lingfeng Chen*. Discovery of a doublecortin-like kinase 1 inhibitor to prevent inflammatory responses in acute lung injury. Bioorganic Chemistry, 2024,145:107215. (一区，IF=5.1)[43-2024.pdf]
42. Xue Han#, Jiajia Wei#, Ruyi Zheng, Yu Tu, Mengyang Wang, Lingfeng Chen, Zheng Xu, Lei Zheng, Chao Zheng, Qiaojuan Shi*，Huazhong Ying*, Guang Liang*. Macrophage SHP2 Deficiency Alleviates Diabetic Nephropathy via Suppression of MAPK/NF-κB-Dependent Inflammation. Diabetes, 2024,73:780–796. (一区，IF=7.7)[42-2024.pdf]
41. Xiaoyu Sun, Shuhong Chen, Ying Zhao, Tong Wu, Zheyu Zhao, Wu Luo, Jibo Han, Zimin Fang, Bozhi Ye, Gang Cao, Shengbin Huang*, Guang Liang*. OTUD6A in tubular epithelial cells mediates Angiotensin II-induced kidney injury by targeting STAT3. American Journal of Physiology-Cell Physiology, 2024,326:C400–C413. (二区，IF=5.5)[41-2024.pdf]
40. Yue Wu#, Yawen Zhang#, Xuanyu Tang, Shuhui Ye, Jingjing Shao, Linglan Tu, junzhi Pan, Lingfeng Chen*, Guang Liang*, and Lina Yin*. Synergistic anti-oxidant and anti-inflammatory effects of Ceria/Resatorvid co-decorated nanoparticles for acute lung injury therapy. Journal of Nanobiotechnology，2023,21:502（一区，IF=10.2）[40-2024.pdf]
39. Li Xiong#, Lingyu She#, Jinfeng Sun1, Xiangwei Xu, Liwei Li, Yuqing Zeng, Hao Tang, Guang Liang*, Wei Wang* and Xia Zhao* . Isolinderalactone Ameliorates the Pathology of Alzheimer's Disease by Inhibiting the JNK Signaling Pathway. Journal of natural products，2023 86 (12), 2718-2729（二区，IF=5.1）[39-2023.pdf]
38. Mengyang Wang#, Tianxiang Yu#, Qinyan Wang, Xue Han, Xiang Hu, Shiju Ye, Xiaohong Long, Yi Wang, Hong Zhu, Wu Luo*, Guang Liang*. OTUD1 Promotes Hypertensive Kidney Fibrosis and Injury by Deubiquitinating CDK9 in Renal Epithelial Cells. Acta Pharmacologica Sinica, 2024,45:765–776(一区，IF=8.2)[38-2024.pdf]
37. Lingyu She#, Hao Tang#, Yuqing Zeng#, Li Xiong, Jinfeng Sun, Liwei Li, Fan Chen, Juan Ren, Jing Zhang, Wei Wang*, Xia Zhao*, Guang Liang*. Ginsenoside RK3 promotes neurogenesis in Alzheimer's disease through activation of the CREB/BDNF pathway. Journal of Ethnopharmacology, 2024,321:117462. (一区，IF=5.4)[37-2024.pdf]
36. Jiajia Zhang#, Yu Tu#, Jiajia Wei, Ruyi Zheng, Ji Shao, Qinhua Chen, Guang Liang, Huazhong Ying*, Xue Han*, Qiaojuan Shi*. Dectin1 contributes to hypertensive vascular injury by promoting macrophage infiltration through activating the Syk/NF-κB pathway. BBA - Molecular Basis of Disease, 2024,1870:166911. (一区, IF=6.2)[36-2024.pdf]
2023年
35. Jinfeng Sun#, Liwei Li#, Li Xiong, Fan Chen, Lingyu She, Hao Tang, Yuqing Zeng, Ying Duan, Yao Lu, Wei Wang, Gao Li*, Xia Zhao*, Guang Liang*. Parthenolide alleviates cognitive dysfunction and neurotoxicity via regulation of AMPK/GSK3β(Ser9)/Nrf2 signaling pathway. Biomedicine & Pharmacotherapy, 2023,169:115909. （一区，IF=7.5）[35-2023.pdf]
34. Tianxiang Yu, Jiachen Xu, Qinyan Wang, Xue Han, Yu Tu, Yi Wang, Wu Luo, Mengyang Wang*, Guang Liang*. 20(S)-ginsenoside Rh2 inhibits Angiotensin-2 mediated cardiac remodeling and inflammation asscociated with suppression of the JNK/AP-1 pathway. Biomedicine & Pharmacotherapy, 2023,169:115880. （一区，IF=7.5）[34-2023.pdf]
33. Huimin Jin, Fan Zhou, Zhenhua Xiang, Lingfeng Chen, Guang Liang*, Patrick J. Walsh*, Jie Li*. Base-Promoted Synthesis of N-H Free Pyrroles via net [3+2]-Cycloaddition. Adv. Synth. Catal, 2023,365:1-6. （二区，IF=5.4）[33-2023.pdf]
32. Lingyu She, Jinfeng Sun, Li Xiong, Ankang Li, Liwei Li, Haibin Wu, Juan Ren, Wei Wang4*, Guang Liang* and Xia Zhao*. Ginsenoside RK1 improves cognitive impairments and pathological changes in Alzheimer's disease via stimulation of the AMPK/Nrf2 signaling pathway. Phytomedicine，2023,122:155168.(一区，IF=7.9）[32-2023.pdf]
31. Minxiu Wang, Qianhui Zhang, Shuaijie Lou, Leiming Jin, Gaojun Wu, Wenqi Wu, Qidong Tang, Yi Wang, Xiaohong Long, Ping Huang, Wu Luo, Guang Liang*. Inhibition of MD2 by natural product-drived JM-9 attenuates renal inflammation and diabetic nephropathy in mice. Biomedicine & Pharmacotherapy, 2023,168:115660.（一区，IF=7.5)[31-2023.pdf]
30. Yawen Zhang, Yue Wu, Yuping Yan, Yijing Ma, Linglan Tu, Jingjing Shao, Xuanyu Tang, Lingfeng Chen, Guang Liang*, Lina Yin*. Dual-Targeted Nanoparticle-In-Microparticle System for Ulcerative Colitis Therapy. Advanced Healthcare Materials, 2023,2301518. (一区, IF=10.0)[30-2023.pdf]
29. Pan Chen, Jun Yang, Ying Zhou, Xiaobo Li, Yu Zou, Zhiwei Zheng, Mi Guo, Zhichao Chen, Won-Jea Cho, Nipon Chattipakorn, Wenqi Wu*, Qidong Tang*, Guang Liang*. Design, synthesis, and bioactivity evaluation of novel amide/sulfonamide derivatives as potential anti-inflammatory agents against acute lung injury and ulcerative colitis. European Journal of Medicinal Chemistry, 2023,259:115706 (一区，IF=6.7）[29-2023.pdf]
28. Bin Yang#, Yunjie Zhao#, Wu Luo#, Weiwei Zhu, Leiming Jin, Minxiu Wang, Lin Ye, Yi Wang*, Guang Liang*. Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway. Cell Death and Disease, 2023,14:419.（二区，IF=9.0）[28-2023.pdf]
27. Xia Zhao#, Jinfeng Sun#, Li Xiong, Lingyu She, Liwei Li, Hao Tang, Yuqing Zeng, Fan Chen, Xue Han, Shiju Ye, Wei Wang, Xu Wang, Guang Liang*. β-amyloid binds to microglia Dectin-1 to induce inflammatory response in the pathogenesis of Alzheimer's disease. International Journal of Biological Sciences, 2023,19:3249-3265.（二区，IF=10.75）[27-2023.pdf]
26. Haibin Wu#, Min Wei#, Shen Hu#, Pu Cheng, Shuhan Shi, Fan Xia, Lenan Xu, Lina Yin, Guang Liang*，Fangyuan Li*, Daishun Ling*. A Photomodulable Bacteriophage-Spike Nanozyme Enables Dually Enhanced Biofilm Penetration and Bacterial Capture for Photothermal-Boosted Catalytic Therapy of MRSA Infections. Advanced Science, 2023, 2301694. （一区，IF=17.521）[26-2023.pdf]
25. Lingfeng Chen#, Lili Fu#, Jingchuan Sun#, Zhiqiang Huang#, Mingzhen Fang#, Allen Zinkle, Xin Liu, Junliang Lu, Zixiang Pan, Yang Wang, Guang Liang, Xiaokun Li*, Gaozhi Chen*, Moosa Mohammadi*. Structural Basis for FGF hormone Signaling. Nature, 2023,618:862.(一区，IF=69.50）[25-2023.pdf]
24. Tianxiang Yu#, Xiangwei Xu#, Jiajia Wei, Jiachen Xu, Wu Luo, Ankang Li, Guang Liang*, Mengyang Wang*. Ginsenoside Rg5 alleviates Ang II–induced cardiac inflammation and remodeling by inhibiting the JNK/AP-1 pathway. International ImmunoPharmacology, 2023,120:110408. (二区，IF=5.71）[24-2023.pdf]
23. Lin Ma#, Yingying Li#, Ruixiang Luo#, Yuhan Wang, Jiaqi Cao, Weitao Fu, Bolan Qian, Lei Zheng, Longguang Tang, Xinting Lv, Lulu Zheng*, Guang Liang*, Lingfeng Chen*. Discovery of a selective and orally bioavailable FGFR2 degrader for treating gastric cancer. Journal of Medicinal Chemistry, 2023,66(11):7438–7453. (一区，IF=8.04）[23-2023.pdf]
22. Mengyang Wang, Xue Han, Tianxiang Yu, Minxiu Wang, Wu Luo, Chunpeng Zou, Xiuyun Li, Gao Li, Gaojun Wu, Yi Wang*, Guang Liang*. OTUD1 Promotes Pathological Cardiac Remodeling and Heart Failure by Targeting STAT3 in Cardiomyocytes. Theranostics, 2023,13(7):2263-2280. (一区，IF=11.6)[22-2023.pdf]
21.Ruixiang Luo#, Weitao Fu#, Jingjing Shao#, Lin Ma#, Sujuan Shuai, Ying Xu, Zheng Jiang, Zenghui Ye, Lulu Zheng, Lei Zheng, Jie Yu, Yawen Zhang, Lina Yin, Linglan Tu, Xinting Lv, Jie Li*, Guang Liang*, Lingfeng Chen*. Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatment. European Journal of Medicinal Chemistry, 2023,253:115305.(一区, IF =7.08)[21-2023.pdf]
20.Jiahao Chen, Wu Luo, Chenghong Hu, Miao Ren, Haowen Xu, Xiangwei Xu, Weifeng Li, Yue Chen, Jingjing Shao, Zhongxiang Xiao, Xinting Lv*, Guang Liang*. Tanshinone IIA analogue 15a inhibits NLRP3-mediated inflammation by activating mitophagy in macrophages to alleviate acute tubular necrosis. International ImmunoPharmacology, 2023,118:110065.(二区，IF=5.71）[20-2023.pdf]
19.Lenan Xu, Meiling Zhang, Junzhi Pan, Xiangwei Xu, Yawen Zhang, Xue Han, Lina Yin, Lingfeng Chen, Juan Ren, Jie Yu, Yanmei Zhang, Guang Liang*, Yi Zhang*. Doxofylline ameliorates liver fibrosis by regulating the ferroptosis signaling pathway. Frontiers in Pharmacology. 2023,1135366. (二区，IF=5.98）[19-2023.pdf]
18.Bowen Zuo#, Wanxin Yao, Mengdie Fang, Juan Ren, Linglan Tu, Runjie Fan, Yanmei Zhang*. Boris knockout eliminates AOM/DSS-induced in situ colorectal cancer by suppressing DNA damage repair and inflammation. Cancer science, 2023,00:1-14.(二区，IF=6.518)[18-2023.pdf]
17.Hao Xu#, Mengdie Fang, Bowen Zuo, Wanxin Yao, Juan Ren, Yanmei Zhang*. circAR-E2E4-miR-665-STAT3 axis is a potential regulatory network in triple-negative breast cancer. Heliyon, 2023,9:e12654.(4区,IF=3.776)[17-2023.pdf]
16.Lili Zhong#, Yuankai Qin#, Mei Liu#, Jinfeng Sun, Hao Tang, Yuqing Zeng, Jing Zhang, Wei Wang, Guang Liang*, Xia Zhao*. Magnoflorine improves cognitive deficits and pathology of Alzheimer's disease via inhibiting of JNK signaling pathway. Phytomedicine, 2023,112:154714.(一区，IF=6.66)[16-2023.pdf]
15.Yi Zhang#, Binhao Cai#, Yingying Li#, Ying Xu, Yuhan Wang, Lulu Zheng, Xiaochun Zheng, Lina Yin, Gaozhi Chen, Yunxiang Wang*, Guang Liang*, Lingfeng Chen*. Identification of Linderalactone as a natural inhibitor of SHP2 to ameliorate CCl4-induced liver fibrosis. Frontiers in Pharmacology, 2023,1098463.(二区, IF=5.98)[15-2023.pdf]
14.Shiju Ye#, Huang He#, Xue Han, Wu Luo, Lili Wu, Yang Ye, Yingchao Gong, Xia Zhao, Weijian Huang, Yi Wang, Xiaohong Long, Guosheng Fu*, Guang Liang*. Dectin-1 acts as a non-classical receptor of Ang II to induce cardiac remodeling. Circulation Research, 2023,132:707-722.(一区，IF=23.2）[14-2023.pdf]
13. Shuhui Ye#, Bowen Zuo#, Lenan Xu, Yue Wu, Ruixiang Luo, Lin Ma, Wanxin Yao, Lingfeng Chen, Guang Liang*, Yanmei Zhang*. Inhibition of SHP2 by the Small Molecule Drug SHP099 Prevents Lipopolysaccharide-Induced Acute Lung Injury in Mice. Inflammation, 2023，132(6):707-722.（二区，IF=4.657) [13-2023.pdf]
12.Lingyu She#, Li Xiong#, Liwei Li, Jing Zhang, Jinfeng Sun, Haibin Wu, Juan Ren, Wei Wang*, Xia Zhao*, Guang Liang*. Ginsenoside Rk3 ameliorates Aβ-induced neurotoxicity in APP/PS1 model mice via AMPK signaling pathway. Biomedicine & Pharmacotherapy, 2023,158:114192.(一区，IF=7.42) [12-2023.pdf]
2022年
11.Hao Xu#, Mengdie Fang, Chao Li, Bowen Zuo, Juan Ren, Yanmei Zhang*. BORIS-mediated generation of circular RNAs induces inflammation. Translational Oncology, 2022,18:101363.(3区,IF=4.803)[11-2022.pdf]
10.Jie Li, Huan Wang, Huimin Jin, Zhenhua Xiang, Lingfeng Chen, Patrick Walsh, Guang Liang*. Base-promoted tandem synthesis of 3,4-dihydroisoquinolones. Organic Letters, 2022,24, 8125-8129. （一区，IF=6.07）[10-2022.pdf]
9.Minxiu Wang, Leiming Jin, Qianhui Zhang, Weiwei Zhu, Hanghui He, Shuaijie Lou, Wu Luo, Xue Han, Guang Liang*. Curcumin analog JM-2 alleviates diabetic cardiomyopathy inflammation and remodeling by inhibiting the NF-κB pathway. Biomedicine & Pharmacotherapy, 2022,154:113590. (二区，IF=7.42）[9-2022.pdf]
8.Yanmei Zhang*,#, Mengdie Fang#, Shouye Li, Hao Xu, Juan Ren, Linglan Tu, Bowen Zuo, Wanxin Yao, Guang Liang*. BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer. Molecular Cancer, 2022,21(1):158.(一区，IF=41）[8-2022.pdf]
7.Jie Li, Dong Zou, Bo Wang, Ayşegül İşcan, Huimin Jin, Lingfeng Chen, Fan Zhou, Patrick J. Walsh*, Guang Liang*. Arylations with nitroarenes for one-pot syntheses of triaryl-methanols and tetraarylmethanes. Organic Chemistry Frontiers, 2022,9,3854.(一区，IF=5.281）[7-2022.pdf]
6.Xia Zhao#,*, Li Xiong#, Lingyu She, Liwei Li, Ping Huang, Guang Liang*. The role and therapeutic implication of Protein tyrosine phosphatases in Alzheimer's disease. Biomedicine & Pharmacotherapy, 2022,151:113188.(二区，IF=7.42）[6-2022.pdf]
5.Xue Han，Jiajia Zhang，Li Zhou，Jiajia Wei，YuTu，Qiaojuan Shi，Yi Zhang，Juan Ren，Yi Wang，Huazhong Ying*，Guang Liang*. Sclareol ameliorates hyperglycemia-induced renal injury through inhibiting the MAPK/NF-κB signaling pathway. Phytotherapy Research, 2022,36(6),2511-2523. (二区，IF=5.878） [5-2022.pdf
4.Wu Luo, Lin Ye, Xueting Hu, Meihong Wang, Minxiu Wang, Leiming Jin, Zhongxiang Xiao, Jianchang Qian, Yi Wang, Wei Zuo, Lijiang Huang, Guang Liang*. MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non‐alcoholic fatty liver disease. Clinical and Translational Medicine, 2022,12(3):e777. (一区，IF=11.49）[4-2022.pdf]
2021年
3.Yawen Zhang, Linglan Tu，Yi Zhang, Jiehao Pan, Gaoli Zheng*, Lina Yin*. Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis. Drug Delivery，2021,28(1):2534–2547. (二区，IF=6.419）[3-2021.pdf]
2.Jie Li, Jiaqi Yao, Lingfeng Chen, Dong Zou, Patrick J. Walsh*, Guang Liang*. Chemoselective acylation of N-acylglutarimides with N-acylpyrroles and aryl esters under transition-metal-free conditions. Organic Chemistry Frontiers, 2021,8:6344–6349. (一区，IF=5.3）[2-2021.pdf]
1.Lingfeng Chen*, Yanmei Zhang, Lina Yin, Binhao Cai, Ping Huang, Xiaokun Li, Guang Liang*. Fibroblast growth factor receptor fusions in cancer: opportunities and challenges. Journal of Experimental & Clinical Cancer Research, 2021,40:345. (一区，IF=11.16）[1-2021.pdf]